Using TTC staining, we showed that the recipient mice receiving monocytes from Sult2b1-/- mice had a larger infarction size and worse neurological scores than those that received monocytes from WT mice (Figure 6C), confirming that monocytes from Sult2b1-/- mice were indeed play a role in worsening the stroke outcomes. The gene discussed is SULT2B1; the disease is infarction.